We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

109 hedge funds and large institutions have $34.4M invested in Sanofi Contingent Value Rights in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 20 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more capital invested

Capital invested by funds: $13.5M → $34.4M (+$20.9M)

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

3% more funds holding

Funds holding: 106 → 109 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

50% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 20

Holders
109
Holders Change
+3
Holders Change %
+2.83%
% of All Funds
2.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
10
Reduced
20
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
+$3.48M
2
FCM
Farallon Capital Management
California
+$438K
3
BHMP
Bardin Hill Management Partners
New York
+$385K
4
ACM
Akanthos Capital Management
California
+$115K
5
PC
Permanens Capital
New York
+$19.4K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$61.8K
2
OAM
Oxford Asset Management
United Kingdom
-$43K
3
DAM
Deltec Asset Management
New York
-$42.6K
4
TI
Telemetry Investments
New York
-$23K
5
TL
TowerView LLC
New York
-$17.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIA
51
Biondo Investment Advisors
Pennsylvania
$4K -$69 -400 -2%
CS
52
Credit Suisse
Switzerland
$4K – – –
HK
53
Horizon Kinetics
New York
$4K – – –
MC
54
Moors & Cabot
Massachusetts
$4K – – –
RIL
55
Rothschild Investment LLC
Illinois
$4K +$2.58K +15,000 New
ISL
56
Ingalls & Snyder LLC
New York
$4K +$2.64K +15,350 New
BlackRock
57
BlackRock
New York
$3K – – –
DA
58
Dillon & Associates
Michigan
$3K – – –
RJA
59
Raymond James & Associates
Florida
$3K – – –
RL
60
Ruffer LLP
United Kingdom
$3K – – –
PNC Financial Services Group
61
PNC Financial Services Group
Pennsylvania
$3K +$136 +790 +7%
Wolverine Trading
62
Wolverine Trading
Illinois
$3K +$2.03K +11,791 New
Bank of Montreal
63
Bank of Montreal
Ontario, Canada
$2K +$1.06K +6,175 +490%
BNP Paribas Financial Markets
64
BNP Paribas Financial Markets
France
$1.31K – – –
MFW
65
Mosaic Family Wealth
Missouri
$1K – – –
Deutsche Bank
66
Deutsche Bank
Germany
$1K +$37 +215 +3%
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$1K +$58 +337 +10%
LTFS
68
Ladenburg Thalmann Financial Services
Florida
$1K +$103 +600 +13%
WEC
69
Winslow Evans & Crocker
Massachusetts
$332 – – –
SIM
70
Sonora Investment Management
Arizona
$300 -$172 -1,000 -44%
SWA
71
Sutton Wealth Advisors
Florida
$81 – – –
MPWT
72
MassMutual Private Wealth & Trust
Connecticut
$11 – – –
ECM
73
Estabrook Capital Management
New York
$3 – – –
TI
74
Telemetry Investments
New York
– -$23K -206,004 Closed
LCM
75
Lonestar Capital Management
California
– -$17K -146,879 Closed
1 2
3
4

GCVRZ Hedge Fund Activity: Q2 2016 in Review

109 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2016, worth a combined $34.4M — up 155% from $13.5M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new GCVRZ positions and 9 closed out — a net gain of 4 holders — while 10 added to existing stakes and 20 trimmed.

The largest buyer was TPG Group Holdings (SBS) Advisors, opening a new position worth an estimated $3.48M. The largest seller was Bank of America, cutting an estimated $61.8K.

  • 109 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2016, up from 106 in Q1 2016.
  • Funds reported $34.4M of Sanofi Contingent Value Rights stock for Q2 2016, up 155% quarter-over-quarter.
  • 13 funds opened new Sanofi Contingent Value Rights positions in Q2 2016 and 9 closed out, a net change of +4 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q2 2016 was TPG Group Holdings (SBS) Advisors, an estimated $3.48M added.
  • The largest Sanofi Contingent Value Rights seller in Q2 2016 was Bank of America, an estimated $61.8K sold.

Based on aggregated 13F filings for Q2 2016.